Abstract

Research Article

Early Outcomes of a Next-Generation Balloon-Expandable Transcatheter Heart Valve - The Myval System: A Single-Center Experience From Serbia

Darko Boljevic*, Milovan Bojic, Mihajlo Farkic, Dragan Sagic, Sasa Hinic, Dragan Topic, Milan Dobric, Jovana Lakcevic, Marko Nikolic, Stefan Veljkovic, Matija Furtula, Jelena Kljajevic and Aleksandra Nikolic

Published: 26 June, 2023 | Volume 8 - Issue 2 | Pages: 072-080

Transcatheter aortic valve implantation (TAVI) is one of the most effective treatments for severe aortic valve stenosis (AVS). Different genres and generations of transcatheter heart valves (THVs) are accessible, offering operators an opportunity to choose a patient-tailored device. In this single-center study, we present the outcomes of Serbian patients treated with next-generation Myval THV for severe symptomatic AVS. Myval THV was implanted in all consecutive patients who underwent TAVI at the Dedinje Cardiovascular Institute of Belgrade, Serbia between October 2020 and September 2021. The primary endpoint was device success on day 30. Secondary endpoints included 30-day all-cause mortality, cardiovascular death, stroke, moderate/severe paravalvular leak (PVL), and new permanent pacemaker implantation (PPI). TAVI was performed as per the European Society of Cardiology guidelines. The study comprised thirteen patients, aged 72±13 years with mean EuroSCORE (7.17%) and Society of Thoracic Surgeons (2.72%,) scores who underwent TAVI successfully with 92.3% using the percutaneous approach. Myval THV intermediate and extra-large sizes were implanted in 46% and 15% of patients, respectively. This acute procedure success rate was 100%. The primary composite endpoint of early device success was achieved in all patients. None of the patients had clinically significant aortic regurgitation or moderate/severe PVL. No patient experienced stroke, contrast-induced acute kidney injury, device-related vascular complications, or a new PPI. The all-cause mortality rate at 30 days was 0%. Myval THV system demonstrated a favorable safety/efficacy profile within 30 days post-procedure at a single center in Serbia. This is the first report of my experience with Myval THV from Serbia.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001156 Cite this Article Read Full Article PDF

Keywords:

Aortic valve stenosis; Transcatheter aortic valve implantation; Myval; Balloon-expandable valve; Serbia; Single-centre experience

References

  1. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013 Sep 10;62(11):1002-12. doi: 10.1016/j.jacc.2013.05.015. Epub 2013 May 30. PMID: 23727214.
  2. Wenaweser P, Praz F, Stortecky S. Transcatheter aortic valve implantation today and tomorrow. Swiss Med Wkly. 2016 Mar 21;146:w14299. doi: 10.4414/smw.2016.14299. PMID: 26999727.
  3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006-8. doi: 10.1161/01.cir.0000047200.36165.b8. PMID: 12473543.
  4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5. PMID: 21639811.
  5. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016 Apr 28;374(17):1609-20. doi: 10.1056/NEJMoa1514616. Epub 2016 Apr 2. PMID: 27040324.
  6. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16. PMID: 30883058.
  7. Kawashima H, Soliman O, Wang R, Ono M, Hara H, Gao C, Zeller E, Thakkar A, Tamburino C, Bedogni F, Neumann FJ, Thiele H, Abdel-Wahab M, Morice MC, Webster M, Rosseel L, Mylotte D, Onuma Y, Wijns W, Baumbach A, Serruys PW. Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial. Am Heart J. 2021 Feb;232:23-38. doi: 10.1016/j.ahj.2020.11.001. Epub 2020 Nov 6. PMID: 33160946.
  8. Sharma SK, Rao RS, Chandra P, Goel PK, Bharadwaj P, Joseph G, Jose J, Mahajan AU, Mehrotra S, Sengottovelu G, Ajit Kumar VK, Manjunath CN, Abhaichand RK, Sethi R, Seth A; Collaborators. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study. EuroIntervention. 2020 Aug 28;16(5):421-429. doi: 10.4244/EIJ-D-19-00413. Erratum in: EuroIntervention. 2020 Aug 28;16(5):429. PMID: 31566572.
  9. García-Gómez M, Delgado-Arana JR, Halim J, De Marco F, Trani C, Martin P, Won-Keun K, Montorfano M, den Heijer P, Bedogni F, Sardella G, IJsselmuiden AJJ, Campante Teles R, Aristizabal-Duque CH, Gordillo X, Santos-Martinez S, Barrero A, Gómez-Salvador I, Ancona M, Redondo A, Román JAS, Amat-Santos IJ. Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients. Catheter Cardiovasc Interv. 2022 Feb;99(3):889-895. doi: 10.1002/ccd.29923. Epub 2021 Aug 14. PMID: 34390296.
  10. Delgado-Arana JR, Gordillo-Monge MX, Halim J, De Marco F, Trani C, Martin P, Infusino F, Ancona M, den Heijer P, Bedogni F, Nombela Franco L, Moreno R, Sargella G, Montorfano M, Aristizabal-Duque C, Romero-Delgado T, Santos S, Barrero A, Gomez Salvador I, IJsselmuiden S, Redondo Diéguez A, San Román Calvar JA, Amat-Santos IJ. Early clinical and haemodynamic matched comparison of balloon-expandable valves. Heart. 2022 May;108(9):725-732. doi: 10.1136/heartjnl-2021-319349. Epub 2021 Jul 20. PMID: 34285104.
  11. Barki M, Ielasi A, Buono A, Maliandi G, Pellicano M, Bande M, Casilli F, Messina F, Uccello G, Briguglia D, Medda M, Tespili M, Donatelli F. Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry. J Clin Med. 2022 Feb 12;11(4):959. doi: 10.3390/jcm11040959. PMID: 35207232; PMCID: PMC8876233.
  12. Kawashima H, Wang R, Mylotte D, Jagielak D, De Marco F, Ielasi A, Onuma Y, den Heijer P, Terkelsen CJ, Wijns W, Serruys PW, Soliman O. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves. Glob Heart. 2021 Mar 19;16(1):20. doi: 10.5334/gh.959. PMID: 33833944; PMCID: PMC7977026.
  13. Santos-Martinez S, Halim J, Castro-Mejía A, De Marco F, Trani C, Martin P, Infusino F, Ancona M, Moreno R, den Heijer P, Nombela-Franco L, Bedogni F, Sardella G, Montorfano M, Revilla-Orodea A, Delgado-Arana JR, Barrero A, Gómez-Salvador I, IJsselmuiden AJJ, Redondo A, Gutiérrez H, Serrador A, Serruys PW, Román JAS, Amat-Santos IJ. Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances. Int J Cardiol. 2022 Mar 15;351:25-31. doi: 10.1016/j.ijcard.2021.12.049. Epub 2022 Jan 1. PMID: 34979152.
  14. Elkoumy A, Jose J, Terkelsen CJ, Nissen H, Gunasekaran S, Abdelshafy M, Seth A, Elzomor H, Kumar S, Bedogni F, Ielasi A, Dora SK, Chandra S, Parikh K, Unic D, Wijns W, Baumbach A, Mylotte D, Serruys P, Soliman O. Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis-A Multicenter Real-World Experience. J Clin Med. 2022 Jan 15;11(2):443. doi: 10.3390/jcm11020443. PMID: 35054137; PMCID: PMC8779274.
  15. Elkoumy A, Jose J, Terkelsen CJ, Nissen H, Gunasekaran S, Abdelshafy M, Seth A, Elzomor H, Kumar S, Bedogni F, Ielasi A, Arsang-Jang S, Dora SK, Chandra S, Parikh K, Unic D, Baumbach A, Serruys P, Soliman O. One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis-A Multicentre Real-World Experience. J Clin Med. 2023 Mar 20;12(6):2398. doi: 10.3390/jcm12062398. PMID: 36983397; PMCID: PMC10054138.
  16. Kumar V, Sengottuvelu G, Singh VP, Rastogi V, Seth A. Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow up Experience From India. Front Cardiovasc Med. 2022 Jul 28;9:817705. doi: 10.3389/fcvm.2022.817705. PMID: 35966565; PMCID: PMC9369256.
  17. Amat-Santos IJ, García-Gómez M, de Marco F, Won-Keun K, Brito J, Halim J, Jose J, Sengotuvelu G, Seth A, Terkelsen C, Protasiewicz M, Bonilla N, García B, Sánchez-Luna JP, Blasco-Turrión S, González JC, González-Bartol E, Ijsselmuiden AJJ, Gómez-Salvador I, Carrasco Moraleja M, San Román A. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study. Rev Esp Cardiol (Engl Ed). 2023 Mar 9:S1885-5857(23)00067-1. English, Spanish. doi: 10.1016/j.rec.2023.03.002. Epub ahead of print. PMID: 36898524.
  18. Blasco-Turrión S, Serrador-Frutos A, Jose J, Sengotuvelu G, Seth A, Aldana VG, Sánchez-Luna JP, Gonzalez-Gutiérrez JC, García-Gómez M, Gómez-Herrero J, Aristizabal C, San Román JA, Amat-Santos IJ. Transcatheter Mitral Valve-in-Valve Implantation with the Balloon-Expandable Myval Device. J Clin Med. 2022 Sep 2;11(17):5210. doi: 10.3390/jcm11175210. PMID: 36079140; PMCID: PMC9457220.
  19. Moscarella E, Ielasi A, Mussayev A, Montorfano M, Mullassari A, Martin P, Testa L, Jose J, Ninios V, Toutouzas K, Giannini F, Kertesz A, Unic D, Nissen H, Ezhumalai B, Senguttuvan NB, Amat-Santos I, Seth A, Bedogni F, Tespili M. Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in patients with bioprosthetic left side heart valves failure: 1-year follow-up from a multicenter experience. Int J Cardiol. 2023 Apr 1;376:35-45. doi: 10.1016/j.ijcard.2023.01.017. Epub 2023 Jan 16. PMID: 36657566.
  20. Halim J, den Heijer P, van den Branden B, Meuwissen M, Vos J, Schölzel B, IJsselmuiden A. Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valve. Neth Heart J. 2022 Dec 8. doi: 10.1007/s12471-022-01738-z. Epub ahead of print. PMID: 36480146.
  21. Kawashima H, Serruys PW, Mylotte D, Rosseel L, Amat-Santos IJ, Rao RS, Onuma Y, Wijns W, Abdel-Wahab M, Baumbach A, Soliman O. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available. Int J Cardiol. 2021 Sep 1;338:168-173. doi: 10.1016/j.ijcard.2021.06.029. Epub 2021 Jun 18. PMID: 34147554.
  22. de Toledo JFB, Teixeirense PT, Guimaraes W, Motta J, Joaquim MR, Odone V, Mantovani J, Alves R, Gubolino LA. In-series transcatheter aortic valve replacement-in-transcatheter aortic valve replacement: ACURATE neo transcatheter heart valve degeneration successfully managed with Myval, Avoiding coronary flow obstruction—A case report. Structural Heart. 2023.
  23. Santos-Martínez S, Redondo A, González-Bartol E, Barrero A, Sánchez-Luna JP, Revilla-Orodea A, Baladrón C, Serrador A, San Román JA, Amat-Santos IJ. Feasibility of precise commissural and coronary alignment with balloon-expandable TAVI. Rev Esp Cardiol (Engl Ed). 2023 Jan;76(1):19-24. English, Spanish. doi: 10.1016/j.rec.2022.03.003. Epub 2022 May 12. PMID: 35570121.
  24. Santos-Martínez S, Amat-Santos IJ, Serrador A, Rodríguez-Gabella T, Gutiérrez H, San Román A. Balloon-expandable Myval transcatheter aortic valve implantation. First experience in Spain. Rev Esp Cardiol (Engl Ed). 2020 Jul;73(7):596-597. English, Spanish. doi: 10.1016/j.rec.2020.01.021. Epub 2020 May 4. PMID: 32376228.
  25. Halim J, den Heijer P, Vos J, Schölzel BE, Meuwissen M, van den Branden B, Baumbach A, Ijsselmuiden AJJ. Balloon-Expandable TAVR Bioprostheses: Area or Perimeter Sizing? A Prospective Pilot Study. J Interv Cardiol. 2022 Oct 18;2022:3139476. doi: 10.1155/2022/3139476. PMID: 36320718; PMCID: PMC9596236.
  26. VARC-3 WRITING COMMITTEE:; Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. 2021 Jun 1;77(21):2717-2746. doi: 10.1016/j.jacc.2021.02.038. Epub 2021 Apr 19. PMID: 33888385.
  27. Nedeljković MA, Beleslin B, Tesić M, Vukcević V, Stanković G, Stojković S, Orlić D, Bilbija I, Matković M, Simić T, Menković N, Mrdović I, Ussia GP, Perisić Z, Babić M. Percutaneous implantation of self-expandable aortic valve in high risk patients with severe aortic stenosis: The first experiences in Serbia. Vojnosanit Pregl. 2016 Feb;73(2):192-7. doi: 10.2298/vsp141117024n. PMID: 27071288.
  28. Boljevic D, Bojic M, Farkic M, Sagic D, Topic D, Kovacevic V, Lakcevic J, Veljkovic S, Dobric M, Hinic S, Ilijevski N, Nikolic M, Kaludjerovic A, Bunc M, Nikolic A. Transcatheter Aortic Valve Implantation: A Report on Serbia's First Systematic Program. Front Cardiovasc Med. 2022 May 24;9:882854. doi: 10.3389/fcvm.2022.882854. PMID: 35686043; PMCID: PMC9170914.
  29. Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2013 Mar;6(3):293-300. doi: 10.1016/j.jcin.2012.09.019. PMID: 23517842.
  30. Lu Q, Pei Y, Wu H, Wang Z, Zaiping J. Transcatheter aortic valve implantation with balloon-expandable valve: early experience from China. Rev Bras Cir Cardiovasc. 2015 Jul-Aug;30(4):425-32. doi: 10.5935/1678-9741.20150054. PMID: 27163416; PMCID: PMC4614925.
  31. Oechslin L, Biaggi P, Wenaweser P, Wyss C, Fritschi D, Gaemperli O, Corti R. Transcatheter Aortic Valve Implantation With Balloon-Expandable Valve Prostheses in Patients With Pure Native Non- or Mildly Calcified Aortic Regurgitation: A Case-Series and Literature Review. J Invasive Cardiol. 2023 May;35(5):E254-E264. PMID: 37219851.
  32. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006 Oct 10;114(15):1616-24. doi: 10.1161/CIRCULATIONAHA.106.639450. Epub 2006 Oct 2. PMID: 17015786.
  33. Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL 3rd, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovasc Interv. 2018 Jan 22;11(2):160-168. doi: 10.1016/j.jcin.2017.10.014. PMID: 29348010.
  34. Schaefer A, Plassmeier F, Schofer N, Vogel L, Ludwig S, Schneeberger Y, Linder M, Demal T, Seiffert M, Blankenberg S, Reichenspurner H, Westermann D, Conradi L. Early commercial experience with a newly designed balloon-expandable transcatheter heart valve: 30-day outcomes and implications of preprocedural computed tomography. Interact Cardiovasc Thorac Surg. 2021 Apr 8;32(3):426-432. doi: 10.1093/icvts/ivaa275. PMID: 33831214; PMCID: PMC8906766.
  35. Testa L, Criscione E, Popolo Rubbio A, Squillace M, Ielasi A, Tespili M, Brambilla N, Bedogni F. Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry. Cardiovasc Revasc Med. 2023 Apr 17:S1553-8389(23)00155-0. doi: 10.1016/j.carrev.2023.04.014. Epub ahead of print. PMID: 37076413.
  36. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G; CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014 Apr 16;311(15):1503-14. doi: 10.1001/jama.2014.3316. PMID: 24682026.
  37. Thiele H, Kurz T, Feistritzer HJ, Stachel G, Hartung P, Eitel I, Marquetand C, Nef H, Doerr O, Lauten A, Landmesser U, Abdel-Wahab M, Sandri M, Holzhey D, Borger M, Ince H, Öner A, Meyer-Saraei R, Wienbergen H, Fach A, Frey N, König IR, Vonthein R, Rückert Y, Funkat AK, de Waha-Thiele S, Desch S. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020 May 21;41(20):1890-1899. doi: 10.1093/eurheartj/ehaa036. PMID: 32049283.
  38. Rheude T, Pellegrini C, Lutz J, Alvarez-Covarrubias HA, Lahmann AL, Mayr NP, Michel J, Kasel MA, Joner M, Xhepa E. Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves: Comparison of SAPIEN 3 Ultra Versus SAPIEN 3. JACC Cardiovasc Interv. 2020 Nov 23;13(22):2631-2638. doi: 10.1016/j.jcin.2020.07.013. Epub 2020 Oct 28. PMID: 33129822.
  39. Medranda GA, Rogers T, Forrestal BJ, Case BC, Yerasi C, Chezar-Azerrad C, Shults CC, Torguson R, Shea C, Parikh P, Bilfinger T, Cocke T, Brizzio ME, Levitt R, Hahn C, Hanna N, Comas G, Mahoney P, Newton J, Buchbinder M, Zhang C, Craig PE, Weigold WG, Asch FM, Weissman G, Garcia-Garcia HM, Ben-Dor I, Satler LF, Waksman R. Balloon-Expandable Valve Geometry After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid Versus Tricuspid Aortic Stenosis. Cardiovasc Revasc Med. 2021 Dec;33:7-12. doi: 10.1016/j.carrev.2021.03.027. Epub 2021 Apr 6. PMID: 34078581.
  40. Abdelshafy M, Serruys PW, Kim WK, Ruck A, Wang R, Tao L, Elkoumy A, Elzomor H, Garg S, Onuma Y, Mylotte D, Soliman O. Quantitative angiographic assessment of aortic regurgitation following 11 TAVR devices: An update of a multicenter pooled analysis. JSCAI. 2022 May 1; 1(3): 100037.
  41. Corcione N, Morello A, Ferraro P, Cimmino M, Testa L, Petronio AS, Iadanza A, Bartorelli AL, Berti S, Regazzoli D, Romagnoli E, Spaccarotella C, Tespili M, Pepe M, Frati G, Biondi-Zoccai G, Giordano A; Registro Italiano GISE sull’Impiantodi Valvola Aortica Percutanea (RISPEVA) Study Investigators. Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study. J Invasive Cardiol. 2021 May;33(5):E320-E329. Epub 2021 Mar 19. PMID: 33739300.
  42. Vlastra W, Chandrasekhar J, Munoz-Garcia AJ, Tchetche D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, Trillo-Nouche R, Dumonteil N, Abizaid A, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Del.

Figures:

Similar Articles

Recently Viewed

  • Update on Mesenchymal Stem Cells
    Khalid Ahmed Al-Anazi* Khalid Ahmed Al-Anazi*. Update on Mesenchymal Stem Cells. J Stem Cell Ther Transplant. 2024: doi: 10.29328/journal.jsctt.1001035; 8: 001-003
  • Macitentan in Adults with Sickle Cell Disease and Pulmonary Hypertension: A Proof-of-Concept Study
    Jeany P Villamizar, Laiqua Khalid, Emilia N Faraj, Thomas J Harrington and David J De La Zerda* Jeany P Villamizar, Laiqua Khalid, Emilia N Faraj, Thomas J Harrington, David J De La Zerda*. Macitentan in Adults with Sickle Cell Disease and Pulmonary Hypertension: A Proof-of-Concept Study. J Pulmonol Respir Res. 2024: doi: 10.29328/journal.jprr.1001055; 8: 029-034
  • Sexual Dimorphism in Autoimmune Disorders
    PD Gupta* PD Gupta*. Sexual Dimorphism in Autoimmune Disorders. Clin J Obstet Gynecol. 2024: doi: ; 7: 056-058
  • A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient
    Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg and Khelif Abderrahim Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg, Khelif Abderrahim. A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001025; 7: 025-028
  • An Unusual Case of Hydatid Cyst Presenting as Pyopneumothorax
    Anand Shweta*, Kumar Vikas and Choudhary Eblow Anand Shweta*,Kumar Vikas,Choudhary Eblow. An Unusual Case of Hydatid Cyst Presenting as Pyopneumothorax. J Pulmonol Respir Res. 2024: doi: 10.29328/journal.jprr.1001050; 8: 001-002

Read More

Most Viewed

Read More

Help ?